Yes, they'll release their robot to a few surgeons in the US this year before trying to expand further next year. Its called the Stanmore Sculptor but is actually the Acrobot which they purchased in 2010. Still need to get their Savile Row implants cleared by the FDA and they are a few years away from a hip solution. Minefield for them to walk with MAKO's patents and their exclusive worldwide license to Immersion Corp.'s entire haptic library for use in orthopedic surgery. It will be interesting to see how it all plays out.
"This new and unique approach to the treatment of osteoarthritis of the knee has been used at a number of leading centres in the UK since the first patient specific personalised knee was implanted in July 2011 and builds upon the earlier clinical work undertaken using the Active Constraint(TM) technology featured in the Sculptor RGA(TM) device. Active Constraint(TM) technology has been shown to provide better functional outcome at 7 year follow up for partial knee surgery compared to the saws and jigs currently used in most knee surgery procedures, which are prone to a much higher degree of placement error.
The Sculptor RGA(TM) will be introduced in the United States for unicompartmental knee surgery in a limited release to a select group of surgeons from mid-2013, as Stanmore continues its evidence based approach to new product introduction. The Company is also developing additional applications for Sculptor RGA(TM) with the goal of broader commercialisation next year."